{
  "url": "https://openlegislation.uk/eu-regulation-2015-1610/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2015-1610/annex.json",
  "legislation": "eur/2015/1610",
  "legislation_title": "Commission Implementing Regulation (EU) 2015/1610 of 24 September 2015 approving Pythium oligandrum strain M1 as an active substance for use in biocidal products for product-type 10 (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2015-1610",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 16(2) of Directive 98/8/EC. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.\nCommon name\nIUPAC nameIdentification numbers\nMinimum degree of purity of the active substance\nDate of approval\nExpiry date of approval\nProduct type\nSpecific conditions\nPythium oligandrum strain M1\nNot applicable\nNo relevant impurities\n1 January 2016\n31 December 2025\n10\nThe product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.\nThe authorisations of biocidal products are subject to the following condition:\nFor industrial or professional users, safe operational procedures and appropriate organisational measures shall be established. Products shall be used with appropriate personal protective equipment where exposure cannot be reduced to an acceptable level by other means.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 16(2) of Directive 98/8/EC. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2015/1610/annex",
    "retrieved_at": "2026-11-01T14:46:27.847191+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}